Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis
NCT07207954
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
176
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
LFD-200
OTHER:
Placebo
DRUG:
Oral Prednisone
OTHER:
Placebo
Sponsor
Lifordi Immunotherapeutics, Inc.